1. Home
  2. LEGT vs DRTS Comparison

LEGT vs DRTS Comparison

Compare LEGT & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGT
  • DRTS
  • Stock Information
  • Founded
  • LEGT 2023
  • DRTS 2015
  • Country
  • LEGT United States
  • DRTS Israel
  • Employees
  • LEGT N/A
  • DRTS N/A
  • Industry
  • LEGT
  • DRTS Medical/Dental Instruments
  • Sector
  • LEGT
  • DRTS Health Care
  • Exchange
  • LEGT Nasdaq
  • DRTS Nasdaq
  • Market Cap
  • LEGT 274.3M
  • DRTS 252.8M
  • IPO Year
  • LEGT 2024
  • DRTS N/A
  • Fundamental
  • Price
  • LEGT N/A
  • DRTS $3.17
  • Analyst Decision
  • LEGT
  • DRTS Strong Buy
  • Analyst Count
  • LEGT 0
  • DRTS 2
  • Target Price
  • LEGT N/A
  • DRTS $8.00
  • AVG Volume (30 Days)
  • LEGT 16.6K
  • DRTS 45.6K
  • Earning Date
  • LEGT 01-01-0001
  • DRTS 08-13-2025
  • Dividend Yield
  • LEGT N/A
  • DRTS N/A
  • EPS Growth
  • LEGT N/A
  • DRTS N/A
  • EPS
  • LEGT 0.29
  • DRTS N/A
  • Revenue
  • LEGT N/A
  • DRTS N/A
  • Revenue This Year
  • LEGT N/A
  • DRTS N/A
  • Revenue Next Year
  • LEGT N/A
  • DRTS N/A
  • P/E Ratio
  • LEGT $0.94
  • DRTS N/A
  • Revenue Growth
  • LEGT N/A
  • DRTS N/A
  • 52 Week Low
  • LEGT $10.10
  • DRTS $1.93
  • 52 Week High
  • LEGT $10.86
  • DRTS $4.39
  • Technical
  • Relative Strength Index (RSI)
  • LEGT N/A
  • DRTS 61.94
  • Support Level
  • LEGT N/A
  • DRTS $2.91
  • Resistance Level
  • LEGT N/A
  • DRTS $3.24
  • Average True Range (ATR)
  • LEGT 0.00
  • DRTS 0.15
  • MACD
  • LEGT 0.00
  • DRTS 0.01
  • Stochastic Oscillator
  • LEGT 0.00
  • DRTS 82.05

About LEGT Legato Merger Corp. III

Legato Merger Corp III is a blank check company.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

Share on Social Networks: